long intergenic non-protein coding RNA 1698Genealiases: []
Q-omics provides the consensus-scored LINC01698 profile across patient tissues and cancer cell-line models. LINC01698 expression is associated with patient survival in 17 of 34 cancer types, with the highest sampling consensus in MESO. Among the 18 cancer types available for tumor–normal comparison, LINC01698 is differentially expressed in 5, with the highest sampling consensus in HNSC. Additionally, LINC01698 RNA expression shows 12,211 significant gene co-expression associations, with the highest sampling consensus in ESCA. Together, these results highlight MESO, HNSC, and ESCA as cancer lineages where LINC01698 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC01698 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC01698 survival associations across molecular data types. LINC01698 RNA expression shows survival associations in the most cancer types (17). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC01698 RNA expression–survival associations across cancer types. High LINC01698 expression shows unfavorable associations in MESO, SKCM, UCEC and KIRC, but favorable associations in KIRP and OV. The MESO Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify MESO as the clearest survival context for LINC01698 RNA expression.
This table summarizes LINC01698 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 5. The strongest signals are observed in HNSC for RNA.
This table ranks reproducible tumor–normal expression differences for LINC01698. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC01698 shows lower tumor expression in STAD and higher tumor expression in HNSC, LUSC, LUAD and KIRC. The HNSC box plot shows higher LINC01698 RNA expression in tumor versus normal tissue (log2 FC = +0.407, t-test p < 0.001).
This table shows molecular features associated with LINC01698 in patient tissues and cancer cell lines. In patient samples, LINC01698 shows the broadest associations at the RNA and protein expression levels, with ESCA recurring as the lineage with the largest associated feature set.
